ITCC-072 INFORM2 NivEnt
INFORM2 exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Promotor Name : KiTZ Heidelberg
Investigator Name : Olaf Witt
INFORM2 exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Promotor Name : KiTZ Heidelberg
Investigator Name : Olaf Witt